NUTX Stock — Nutex Health Inc.

Nutex Health Inc. (NUTX)

Updated October 16, 2026.

NUTX is a Stock. Its deepest 1-year drawdown was 54.3%.

Nutex Health Inc. operates a network of micro hospitals, specialty hospitals, and outpatient departments across the United States, alongside a population health management segment that provides administrative and technology services to affiliated providers and physician networks, and a real estate segment that owns and leases healthcare facilities. The company does not currently distribute to shareholders. This business appeals primarily to investors seeking equity exposure to healthcare operations rather than current income.

NUTX performance

Returns are updating. NUTX's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 54.3%.

NUTX key facts

Asset type

Stock

Asset class

Equity

Inception date

04/08/2013

Distribution frequency

None

Last close

$186.10 (as of 2026-10-16)

Market cap

$1,274,407,775

Average volume

121055.0

Payment date

11/01/2019

Beta

2.003

Payout ratio

0.0%

P/E ratio

7.37

Forward P/E

9.877

EPS

$25.24

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

NUTX risks and drawbacks

The deepest 1-year drawdown on record here is 54.3%.

Who may consider NUTX — and who may not

It is a weaker fit for investors who need monthly cash flow (NUTX does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on NUTX

• All tickers starting with N

Tagged: Healthcare.

Frequently asked questions